Guangyao Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guangyao Liu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Changfu Zhao
Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130001, P.R. China
1 shared publication- Changhua Zhang
Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China
1 shared publication Hongwu Fan
Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130001, P.R. China
1 shared publicationHuijin Wang
Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, No.628, Zhen yuan Road, Guang ming District, Shenzhen, 518107, China
1 shared publicationSongyao Chen
Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, No.628, Zhen yuan Road, Guang ming District, Shenzhen, 518107, China
1 shared publication- Wei Chen
Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, No.628, Zhen Yuan Road, Guangming District, Shenzhen, 518107, China
1 shared publication
Latest Publications
- Open Access
- 28 December 2022
- Published by Elsevier in Experimental Cell Research
- Vol. 423 (1) , 113453
Downregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-STAT3 pathway in gastric cancer
- 28 December 2022
- Published by Elsevier in Experimental Cell Research
- Vol. 423 (1) , 113453
Open AccessDownregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-STAT3 pathway in gastric cancer
- Open Access
- 21 November 2016
- Published by Spandidos Publications in Oncology Letters
- Vol. 13 (1) , 396-402
Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347
Osteosarcoma is the most common primary bone tumor in children and adolescents, typically presenting with a poor prognosis. Octamer-binding transcription factor 4 (Oct4) protein, encoded by the POU class 5 homeobox 1 gene, is important in maintaining self-renewal of pluripotent stem cells, and is closely associated with cancer. However, its role in osteosarcoma remains to be elucidated. The present study observed Oct4 was markedly increased in osteosarcoma cell lines and in human osteosarcoma tissue samples. Following Oct4 downregulation by small interfering RNA (siRNA) in osteosarcoma F5M2 cells, the cells exhibited significant decreases in proliferation and invasion ability, and an increase in cell apoptosis. Notably, downregulation of Oct4 decreased the expression of AK055347, a newly identified long noncoding RNA (lncRNA) in human tissues. The downregulation of AK055347 by siRNA resulted in a significant suppressive effect on proliferative and invasive ability, and promotion of cell apoptosis in osteosarcoma cells. Thus, the current study suggests Oct4 exerts a promoting effect in osteosarcoma, and identifies a novel lncRNA in osteosarcoma progression.
- 21 November 2016
- Published by Spandidos Publications in Oncology Letters
- Vol. 13 (1) , 396-402
Open AccessTranscription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347
Osteosarcoma is the most common primary bone tumor in children and adolescents, typically presenting with a poor prognosis. Octamer-binding transcription factor 4 (Oct4) protein, encoded by the POU class 5 homeobox 1 gene, is important in maintaining self-renewal of pluripotent stem cells, and is closely associated with cancer. However, its role in osteosarcoma remains to be elucidated. The present study observed Oct4 was markedly increased in osteosarcoma cell lines and in human osteosarcoma tissue samples. Following Oct4 downregulation by small interfering RNA (siRNA) in osteosarcoma F5M2 cells, the cells exhibited significant decreases in proliferation and invasion ability, and an increase in cell apoptosis. Notably, downregulation of Oct4 decreased the expression of AK055347, a newly identified long noncoding RNA (lncRNA) in human tissues. The downregulation of AK055347 by siRNA resulted in a significant suppressive effect on proliferative and invasive ability, and promotion of cell apoptosis in osteosarcoma cells. Thus, the current study suggests Oct4 exerts a promoting effect in osteosarcoma, and identifies a novel lncRNA in osteosarcoma progression.